AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. (Q30367603)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. |
scientific article |
Statements
1 reference
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial. (English)
1 reference
1 reference
Louise Frenette
1 reference
Mamadou Drame
1 reference
Pope Kosalaraksa
1 reference
Robert Jeanfreau
1 reference
Miguel Madariaga
1 reference
Olivier Godeaux
1 reference
Patricia Izurieta
1 reference
David W Vaughn
1 reference
6 October 2014
1 reference
1 reference
211
1 reference
801-810
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference